Medical Condition News

RSS

Nanotechnology for study of individual molecule interaction in live cells

A University of Alberta-led research team has taken a major step forward in understanding how T cells are activated in the course of an immune response by combining nanotechnology and cell biology. T cells are the all important trigger that starts the human body's response to infection.

29 Apr 2010

Genetic test to predict newborns requiring hospital readmission shortly after birth

The results of two separate research studies taking place at Children's Mercy Hospitals and Clinics will help physicians use genetic testing to prevent complications, and ease the worry of new parents by predicting in advance which newborns may require readmission to the hospital shortly after birth. The studies also will help physicians identify which of their young patients are likely to respond well - or not - to steroid therapy for asthma.

29 Apr 2010

Removing unruptured AVM decreases risk of hemorrhaging, provides better outcomes to patients

Individuals diagnosed with a brain arteriovenous malformation, an abnormal tangle of arteries and veins, are at an increased risk of vessel rupture and bleeding that can cause stroke and permanent brain damage.

29 Apr 2010

Cardiac Science responds to FDA communications on AED recall

Cardiac Science Corporation, responded to FDA communications released yesterday related to the AED recall first announced in November, 2009. The Agency communication specifies additional affected models and offers further guidance to users of AEDs affected by potential component defects in some of the Company's AEDs.

29 Apr 2010

Panel finds insufficient evidence to support preventive measures for cognitive decline, Alzheimer's disease

Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.

29 Apr 2010

Albireo to present study results of A3309 in patients with chronic constipation at 2010 DDW annual meeting

Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.

29 Apr 2010

Air pollution can damage heart and lead to increased risk of heart disease: Study

A post-mortem study of the hearts of 21 young people in Mexico City has found that the heart begins to show the adverse effects of air pollution at a young age and that tiny bits of inactivated bacteria that hitch a ride on pollutants may make the problem worse.

29 Apr 2010

CINJ trial targets new combination therapy for advanced solid tumors

Building off recent laboratory discoveries relating to how cancer cells become resistant to therapies that attempt to starve cancer, scientists at The Cancer Institute of New Jersey (CINJ) are now applying that knowledge to a process in which cancer cells eat themselves to downsize and resist therapy. The ultimate goal of this effort is to improve upon current anticancer treatments.

29 Apr 2010

Researchers develop lottery game to assess extent of spatial neglect

Patients recovering from stroke sometimes behave as if completely unaware of one half of the world: colliding with obstacles on their left, eating food only from the right side of their plate, or failing to dress their left side. This puzzling phenomenon is termed "spatial neglect" and it affects roughly 45% of patients suffering from a stroke in the right side of the brain.

29 Apr 2010

Most parents restrict playtime activities for asthmatic children

New data released today find that 82 percent of parents of children ages 4-12 with asthma report having restricted playtime activities to help avoid triggers and prevent asthma attacks in their children, with 47% of them keeping children with asthma inside when allergy season is in full swing. Working parents, who more often report experiencing stress related to raising a child with asthma than non-working parents (44% vs. 38%), take more precautions, such as more often swapping carpeting for wood flooring (30% vs. 17%).

29 Apr 2010

Improved management practices can reduce annual costs from diabetes-related complications

Milliman Inc., a premier global consulting and actuarial firm, today released an analysis detailing the economic burden of type 2 diabetes on major healthcare payers and quantifying the savings that could result from better patient management practices.

29 Apr 2010

Astrazeneca settles drug marketing lawsuit, plea deal rejected for possibly defective heart device maker

The New York Times: AstraZeneca has settled a case and agreed to pay $520 million after federal investigations into its marketing practices for a schizophrenia drug, Seroquel. The announcement came Tuesday from Attorney General Eric Holder. Government officials, including Health and Human Services Secretary Kathleen Sebelius, said the company paid illegal kickbacks to doctors to promote drugs for unapproved uses by children, the elderly, veterans and prisoners, which is illegal under federal law.

29 Apr 2010

Pain Therapeutics reports net loss of $1.0 million for first-quarter 2010

Pain Therapeutics, Inc., a biopharmaceutical company, today reported first quarter 2010 financial results. Net loss for Q1 2010 was $1.0 million, or $0.02 per share, compared to a net loss of $1.8 million, or $0.04 per share, for Q1 2009.

29 Apr 2010

OSI Pharmaceuticals announces European Commission's approval of Tarceva for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, received approval from the European Commission for Tarceva as a monotherapy maintenance treatment in patients with advanced non-small cell lung cancer (NSCLC) whose disease remains largely unchanged (stable disease) after platinum-based initial chemotherapy.

29 Apr 2010

Physicists and oncologists to develop novel ultra sensitive platform for early cancer detection

The SPEDOC project will create the precursor to future devices for individualized diagnosis and monitoring of cancer therapy, which will allow the illness to be treated in earlier stages and at lower doses, reducing or preventing current secondary effects.

29 Apr 2010

New report evaluating use of SBRT in lung cancer treatment released

The American Society for Radiation Oncology has released its Emerging Technology Committee's report evaluating the use of stereotactic body radiotherapy in lung cancer treatment.

29 Apr 2010

Roche announces results of phase III T-emerge 3 study of taspoglutide in diabetics

Ipsen, a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with diabetes with taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence. Taspoglutide originating from Ipsen's research is developed by Roche.

29 Apr 2010

Elderly and whites seek alternative therapies for pain relief: Study

In a University of Michigan Health System study, 1 out of 3 patients with chronic pain reported using complementary and alternative medicine therapies such as acupuncture and chiropractic visits for pain relief.

29 Apr 2010

Endovascular repair and surveillance appear to be safe alternatives for patients with small aneurysms

While repair of large abdominal aortic aneurysms (AAA's) is well accepted, randomized clinical trials have failed to demonstrate benefit for early surgical repair of small aneurysms over surveillance, according to researchers from New York-Presbyterian Hospital in New York.

29 Apr 2010

Higher the blood cholesterol level, greater the risk of atherosclerosis: Study

In addition to crystallized cholesterol, atherosclerotic plaques always contain large quantities of immune cells but, surprisingly, no bacteria or viruses. It was previously unclear just how the body's own defence forces are called into action. Even animals that are kept in an absolutely sterile environment can suffer from "clogging" or "furring" of the arteries when their food contains high levels of cholesterol.

29 Apr 2010

Medical Condition News

Nanotechnology for study of individual molecule interaction in live cells

Genetic test to predict newborns requiring hospital readmission shortly after birth

Removing unruptured AVM decreases risk of hemorrhaging, provides better outcomes to patients

Cardiac Science responds to FDA communications on AED recall

Panel finds insufficient evidence to support preventive measures for cognitive decline, Alzheimer's disease

Albireo to present study results of A3309 in patients with chronic constipation at 2010 DDW annual meeting

Air pollution can damage heart and lead to increased risk of heart disease: Study

CINJ trial targets new combination therapy for advanced solid tumors

Researchers develop lottery game to assess extent of spatial neglect

Most parents restrict playtime activities for asthmatic children

Improved management practices can reduce annual costs from diabetes-related complications

Astrazeneca settles drug marketing lawsuit, plea deal rejected for possibly defective heart device maker

Pain Therapeutics reports net loss of $1.0 million for first-quarter 2010

OSI Pharmaceuticals announces European Commission's approval of Tarceva for NSCLC

Physicists and oncologists to develop novel ultra sensitive platform for early cancer detection

New report evaluating use of SBRT in lung cancer treatment released

Roche announces results of phase III T-emerge 3 study of taspoglutide in diabetics

Elderly and whites seek alternative therapies for pain relief: Study

Endovascular repair and surveillance appear to be safe alternatives for patients with small aneurysms

Higher the blood cholesterol level, greater the risk of atherosclerosis: Study

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News